logo

Clearside Biomedical, Inc. (CLSD)



Trade CLSD now with
  Date
  Headline
5/9/2019 7:50:06 AM Wedbush Is Raising Clearside Biomedical, Inc. (CLSD) FY20 Rev. Estimate To 7.6 M From 7.4 M
5/9/2019 7:49:50 AM Wedbush Is Raising Clearside Biomedical, Inc. (CLSD) Q3 20 Rev. Estimate To 2.1 M From 2.0 M
5/9/2019 7:49:36 AM Wedbush Is Increasing Clearside Biomedical, Inc. (CLSD) Q2 20 Rev. Estimate To 1.6 M From 1.5 M
5/9/2019 7:49:25 AM Wedbush Is Increasing Clearside Biomedical, Inc. (CLSD) Q1 20 Rev. Estimate To 1.2 M From 1.1 M
5/9/2019 7:48:56 AM Wedbush Is Lowering Clearside Biomedical, Inc. (CLSD) FY20 Estimate To -1.38 From -0.82
5/9/2019 7:48:38 AM Wedbush Is Cutting Clearside Biomedical, Inc. (CLSD) Q4 20 Estimate To -0.39 From -0.23
5/9/2019 7:48:26 AM Wedbush Is Lowering Clearside Biomedical, Inc. (CLSD) Q3 20 Estimate To -0.36 From -0.21
5/9/2019 7:48:08 AM Wedbush Is Lowering Clearside Biomedical, Inc. (CLSD) Q2 20 Estimate To -0.33 From -0.20
5/9/2019 7:47:56 AM Wedbush Is Lowering Clearside Biomedical, Inc. (CLSD) Q1 20 Estimate To -0.31 From -0.18
5/9/2019 7:47:36 AM Wedbush Is Lowering Clearside Biomedical, Inc. (CLSD) FY19 Estimate To -1.37 From -0.79
5/9/2019 7:46:59 AM Wedbush Is Cutting Clearside Biomedical, Inc. (CLSD) Q4 19 Estimate To -0.31 From -0.19
5/9/2019 7:46:45 AM Wedbush Is Cutting Clearside Biomedical, Inc. (CLSD) Q3 19 Estimate To -0.29 From -0.18
5/9/2019 7:46:25 AM Wedbush Is Lowering Clearside Biomedical, Inc. (CLSD) Q2 19 Estimate To -0.33 From -0.19
5/9/2019 7:45:50 AM Wedbush Reiterates Clearside Biomedical, Inc. (CLSD) At Outperform With $4 Price Target
5/11/2018 11:20:00 AM Wedbush Is Cutting Clearside Biomedical, Inc. (CLSD) FY19 Estimate To -2.72 From -2.63
5/11/2018 11:19:45 AM Wedbush Is Lowering Clearside Biomedical, Inc. (CLSD) FY18 Estimate To -2.27 From -2.10
5/11/2018 11:19:30 AM Wedbush Is Cutting Clearside Biomedical, Inc. (CLSD) Q4 18 Estimate To -0.61 From -0.59
5/11/2018 11:19:16 AM Wedbush Is Lowering Clearside Biomedical, Inc. (CLSD) Q3 18 Estimate To -0.53 From -0.51
5/11/2018 11:19:03 AM Wedbush Is Lowering Clearside Biomedical, Inc. (CLSD) Q2 18 Estimate To -0.52 From -0.50
5/11/2018 11:18:24 AM Wedbush Reiterates Clearside Biomedical, Inc. (CLSD) At Outperform With $29 Price Target